| CCH | 12-Feb-26 |
Sell |
Anastassis G David |
4,710.65p | 29,277 |
£1,379,137.97 |
| SGE | 12-Feb-26 |
Buy |
John Bates |
810.97p | 35,000 |
£283,839.51 |
| CCH | 11-Feb-26 |
Sell |
Anastassis G David |
4,712.83p | 2,991 |
£140,960.64 |
| UU. | 11-Feb-26 |
Buy |
Louise Beardmore |
1,298.25p | 13 |
£168.77 |
| UU. | 11-Feb-26 |
Buy |
Phil Aspin |
1,298.25p | 13 |
£168.77 |
| CCH | 12-Feb-26 |
Sell |
Anastassis G David |
4,710.65p | 29,277 |
£1,379,137.97 |
| EXPN | 06-Feb-26 |
Buy |
Esther Lee |
2,511.46p | 10,398 |
£261,141.87 |
| SGE | 12-Feb-26 |
Buy |
John Bates |
810.97p | 35,000 |
£283,839.51 |
| CCH | 11-Feb-26 |
Sell |
Anastassis G David |
4,712.83p | 2,991 |
£140,960.64 |
| GSK | 09-Feb-26 |
Sell |
Luke Miels |
2,211.40p | 4,549 |
£100,596.59 |
| REL |
2,192.00p |
+6.8% |
| EXPN |
2,540.00p |
+5.5% |
| RR. |
1,270.50p |
+3.6% |
| III |
3,364.00p |
+2.9% |
| PSH |
4,492.00p |
+2.5% |
| MRO |
638.00p |
+2.4% |
| LSEG |
7,694.00p |
+2.3% |
| HLMA |
3,828.00p |
+2.3% |
| TSCO |
486.30p |
+2.2% |
| MTLN |
35.47 |
+2.2% |
| FLTR |
9,660.00p |
-8.0% |
| NWG |
573.60p |
-3.6% |
| PRU |
1,045.00p |
-3.5% |
| LLOY |
99.16p |
-3.2% |
| BARC |
449.15p |
-3.1% |
| ENT |
579.20p |
-2.7% |
| HSBA |
1,234.60p |
-2.5% |
| AAL |
3,500.00p |
-2.3% |
| STAN |
1,690.50p |
-2.3% |
| BTRW |
384.80p |
-2.1% |
Top of Page
You are here:
research